Yavuz Dilek Gogas, Yüksel Meral, Deyneli Oguzhan, Ozen Yesim, Aydin Hasan, Akalin Sema
Marmara University Medical School, Division of Endocrinology and Metabolism, Istanbul, Turkey.
Clin Endocrinol (Oxf). 2004 Oct;61(4):515-21. doi: 10.1111/j.1365-2265.2004.02123.x.
Low serum paraoxonase (PON) activity is thought to be a risk factor for the development of atherosclerosis. The present study was designed to evaluate PON1 activity and its relationship with preatherosclerotic markers such as lipid peroxidation and insulin resistance in hyperthyroid patients before and after propylthiouracil (PTU) treatment and in subjects with iatrogenic subclinical hyperthyroidism.
Twenty patients with hyperthyroidism, 20 patients with euthyroid multinodular goiter (MNG) and 20 age- and sex-matched healthy controls were enrolled in the study. Insulin sensitivity index, PON activity and lipid peroxidation were measured at baseline and 2 months after achieving euthyroidism or subclinical hyperthyroidism. Levothyroxine was given as a part of TSH suppression therapy in multinodular goitre patients.
Insulin sensitivity was determined by an oral glucose tolerance test (OGTT) based on the insulin sensitivity index (ISI) formula, serum paraoxonase activity was determined with a spectrophotometric method. Lipid peroxidation was measured by the formation of thiobarbituric acid reactive substances (TBARs).
ISI was significantly lower in the hyperthyroid group than baseline levels in MNG patients and controls (P < 0.001). While ISI increased after treatment in the hyperthyroid group (P < 0.01), it significantly decreased with L-T4 treatment in the MNG group (P < 0.01). Serum paraoxonase activity was significantly lower in the hyperthyroid group before treatment than baseline and final measurements of other groups (P < 0.05). While PON activity increased after restoration of the euthyroid state in the hyperthyroid group (P < 0.05), it decreased with L-T4 treatment in the MNG group (P < 0.05). Lipid peroxidation was significantly higher in hyperthyroid group compared to baseline levels of other groups (P < 0.05). It decreased after treatment in the hyperthyroid group (P < 0.05) but a significant increase was observed following L-T4 treatment in the MNG group (P < 0.05). Serum paraoxonase activity was found to be negatively correlated with serum TT4 (r = -0.32, P = 0.003), TT3 levels (r = -0.31, P = 0.004), TBARs levels (r = 0.32, P = 0.003) and positively correlated with ISI (r = 0.35, P = 0.001) and high-density lipoprotein (HDL) cholesterol levels (r = 0.35, P = 0.0011) in the hyperthyroid and MNG groups.
Iatrogenic thyroid hormone excess seems to mimic the effects of endogenous thyroid hormone excess on paraoxonase activity, insulin sensitivity and oxidative stress. These findings suggest that TSH suppression with levothyroxine may increase oxidative stress and LDL oxidation and thereby promote atherogenesis.
血清对氧磷酶(PON)活性降低被认为是动脉粥样硬化发生的一个危险因素。本研究旨在评估丙硫氧嘧啶(PTU)治疗前后甲状腺功能亢进患者以及医源性亚临床甲状腺功能亢进患者的PON1活性及其与动脉粥样硬化前期标志物如脂质过氧化和胰岛素抵抗的关系。
本研究纳入了20例甲状腺功能亢进患者、20例甲状腺功能正常的多结节性甲状腺肿(MNG)患者以及20例年龄和性别匹配的健康对照者。在达到甲状腺功能正常或亚临床甲状腺功能亢进状态的基线及2个月后,测量胰岛素敏感性指数、PON活性和脂质过氧化。多结节性甲状腺肿患者接受左甲状腺素作为促甲状腺激素抑制治疗的一部分。
基于胰岛素敏感性指数(ISI)公式通过口服葡萄糖耐量试验(OGTT)测定胰岛素敏感性,用分光光度法测定血清对氧磷酶活性。通过硫代巴比妥酸反应性物质(TBARs)的形成来测量脂质过氧化。
甲状腺功能亢进组的ISI显著低于MNG患者和对照组的基线水平(P < 0.001)。甲状腺功能亢进组治疗后ISI升高(P < 0.01),而MNG组接受L-T4治疗后ISI显著降低(P < 0.01)。甲状腺功能亢进组治疗前血清对氧磷酶活性显著低于其他组的基线和最终测量值(P < 0.05)。甲状腺功能亢进组恢复甲状腺功能正常状态后PON活性升高(P < 0.05),而MNG组接受L-T4治疗后PON活性降低(P < 0.05)。与其他组的基线水平相比,甲状腺功能亢进组的脂质过氧化显著更高(P < 0.05)。甲状腺功能亢进组治疗后脂质过氧化降低(P < 刚0.05),但MNG组接受L-T4治疗后脂质过氧化显著升高(P < 0.05)。在甲状腺功能亢进组和MNG组中,发现血清对氧磷酶活性与血清总甲状腺素(TT4)(r = -0.32,P = 0.003)、总三碘甲状腺原氨酸(TT3)水平(r = -0.31,P = 0.004)、TBARs水平(r = 0.32,P = 0.003)呈负相关,与ISI(r = 0.35,P = 0.001)和高密度脂蛋白(HDL)胆固醇水平(r = 0.35,P = 0.0011)呈正相关。
医源性甲状腺激素过量似乎模拟了内源性甲状腺激素过量对血清对氧磷酶活性、胰岛素敏感性和氧化应激的影响。这些发现表明,用左甲状腺素抑制促甲状腺激素可能会增加氧化应激和低密度脂蛋白氧化,从而促进动脉粥样硬化的发生。